Cerus Corporation (CERS) vs ClearPoint Neuro, Inc. (CLPT)
Cerus Corporation and ClearPoint Neuro, Inc. are both Medical Devices companies. Cerus Corporation is the larger, with a market value of $524.0M against $445.7M — 1.2× the size. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 14.6%. Cerus Corporation has the higher net margin (−2.73% vs −81.8%) and the higher return on invested capital (−1.27% vs −61.3%). Across the 18 metrics below, Cerus Corporation leads on 13 and ClearPoint Neuro, Inc. on 5.
Valuation
Profitability
| Metric | CERS | CLPT | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.16% | 62.61% | 56.01% |
| Operating margin | (0.65%) | (73.42%) | (15.03%) |
| Net margin | (2.73%) | (81.76%) | (20.40%) |
| Free cash flow margin | (0.74%) | (74.01%) | (7.24%) |
| Return on equity | (10.69%) | (226.52%) | (15.32%) |
| Return on assets | (3.24%) | (46.21%) | (19.72%) |
| Return on invested capital | (1.27%) | (61.31%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack